openPR Logo
Press release

Tularemia Market Ready to Reach at a US$ 200 Million by 2023

01-23-2018 06:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Tularemia Market

Tularemia Market

The Global Tularemia Market is expected to reach US$ 200 million by 2023, and the market is projected to grow at a CAGR of ~ 3.2 % during the forecast period 2017-2023.
Tularemia or rabbit fever or deer fly fever is a rare infectious disease caused by the bacterium Francisella tularensis, which affects skin, eyes, lymph nodes and lungs. Tularemia is transmitted from animals such as rodents, rabbits, and hares to human. It can also affect sheep, birds, dogs, cats, etc. The routes of acquiring infection are direct exposure to the bacteria, airborne infections, insect bites, and bite of an infected animal. Tularemia is highly contagious and had been used as a biological weapon by many countries such as United States of America and Soviet Union. Ulceroglandular tularemia is the most common form of Tularemia. Tularemia symptoms include swollen and painful lymph glands, fever, chills, headache, fatigue, eye swelling, pain and light sensitivity, diarrhea, pneumonia etc. If it left untreated, it will cause serious complications such as enlarged spleen, enlarged liver, infection around the brain and spinal cord, irritation around the heart (pericarditis), bone infection etc. and may lead to the death.
Key Players in the Global Tularemia Market:
Nicholas Piramal, Alkem, Glaxo Smithkline, Bayer AG, Ranbaxy Laboratories, Cipla Inc., Zydus Cadila, Dr. Reddy's Lab, Glenmark Pharmaceuticals, Lupin Limited, pfizer Inc. and others.
Request a Sample Report at https://www.marketresearchfuture.com/sample_request/4120 .
Factors favouring the spread of Tularemia infection are tick bites, exposure to sick or dead animals, especially, wild game. Travel to certain regions such as Arkansas, Missouri and Oklahoma can also cause Tularemia infection because of the concentration of ticks in those areas. Tick bite is the leading cause for an occurrence of large number of cases.Laboratory workers working with tularemia are at risk of airborne infection due to greater chances of exposure to the pathogen. Tularemia infection can also be airborne during gardening, construction or other activities, which may lead to pneumonic tularemia. Tularemia is also contracted by eating undercooked meat of an infected animal or drinking contaminated water. According to Centers for Disease Control and Prevention, overall mortality of Tularemia is less than 2% but ranges up to 24% depending on the strain.
The Global Tularemia Market has been segmented on the basis of types, diagnosis, drugs, and end users.
Based on types, the market has been segmented as the ulceroglandular tularemia, glandular tularemia, oculoglandular tularemia, oropharyngeal tularemia, pneumonic tularemia, and others.
Based on the diagnosis, the market has been segmented as microscopy, immunochemistry, and others.
Based on the drugs, the market has been segmented as streptomycin, gentamicin, doxycycline, ciprofloxacin and others.
Based on the end users, the market has been segmented as hospitals and clinics, academic and research centers, and others.
Ask Question to Expert at https://www.marketresearchfuture.com/enquiry/4120 .
Tularemia Market Regional analysis:
The Americas accounts for the significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the Global Tularemia Market. However the presence and concentration of Tularemia in the US regions, for instance, Arkansas, Missouri, Dakota, Oklahoma, etc. are the leading cause for the dominance of US in the Global Tularemia Market. Europe is the second largest market in the globe due to a high disposable income and rising awareness about the disease.
Asia Pacific region is expected to grow rapidly and China and India are likely to lead the market due to unmet needs during the forecast period.
Gulf nations such as Saudi Arabia and the UAE drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. However Africa is also a region of high endemic and untreated cases of Tularemia.
Table of Content:
1. Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4. Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Tularemia Market, By Type
5.1 Ulceroglandular Tularemia
5.2 Glandular Tularemia
5.3 Oculoglandular Tularemia
5.4 Oropharyngeal Tularemia
5.5 Pneumonic TularemiA
5.6 Others
…Continued
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

MRFR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Years of research into diverse fields of work has ingrained within us, a proficiency so distinguished that our industry-specific specialists identify with your business ideas and feel the pulse of your challenges and opportunities. This enables us for providing assistance, through our consulting and strategic consulting services, in informed managerial decision making. In order to stay updated with technology and work process of the industries, WantStats Research and Media often conducts industrial visits for its research analysts. Relevant inputs from various established market participants, help our clients make significant contribution in respective markets are a huge motivation for all of us to endlessly furnish quality. We depend greatly on profound insights into complex realms of our study.

Pune, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tularemia Market Ready to Reach at a US$ 200 Million by 2023 here

News-ID: 913941 • Views:

More Releases from Market Research Future

Cerebral Palsy Industry Projected to Reach USD 4.036 billion by 2035 with Steady Long-Term Growth
Cerebral Palsy Industry Projected to Reach USD 4.036 billion by 2035 with Steady …
The global healthcare sector continues to place increasing emphasis on neurological disorders that require long-term management and multidisciplinary care. Among these, cerebral palsy remains one of the most common childhood motor disabilities, affecting movement, posture, and muscle coordination. As awareness grows and treatment options continue to advance, the cerebral palsy industry is witnessing steady expansion driven by improved diagnosis, therapeutic innovation, and rising investments in rehabilitation services. According to Market Research
Reclaimed Lumber Market revenue expected to rise from USD 53.47 Billion in 2024 to USD 85.52 Billion by 2035
Reclaimed Lumber Market revenue expected to rise from USD 53.47 Billion in 2024 …
Based on the market research report from Market Research Future, here is a detailed overview of the global reclaimed lumber market. This sector is thriving at the intersection of environmental sustainability and distinctive design. What is Reclaimed Lumber? Reclaimed lumber is wood sourced from old structures like barns, factories, warehouses, and wine barrels, which is then processed and remilled for new use. It offers a unique combination of environmental benefits-reducing deforestation and
Cardiovascular Information Systems Industry Expected to Reach USD 1,330.86 million by 2035 with Steady Growth Momentum
Cardiovascular Information Systems Industry Expected to Reach USD 1,330.86 milli …
The global healthcare sector is undergoing a rapid digital transformation, particularly in specialized areas such as cardiovascular care where data accuracy, workflow efficiency, and real-time monitoring are critical. Cardiovascular Information Systems (CVIS) have emerged as essential platforms that integrate imaging, patient records, diagnostic data, and clinical workflows to support comprehensive cardiac care management. According to Market Research Future (MRFR), the Cardiovascular Information System Market was valued at USD 640.0 million in
Low E-Glass Industry forecast highlights robust 6.5% CAGR growth through 2035
Low E-Glass Industry forecast highlights robust 6.5% CAGR growth through 2035
Low-emissivity (Low-E) glass has a microscopically thin, transparent coating that reflects infrared energy (heat) while allowing visible light to pass through. This principle helps keep buildings warm in the winter by reflecting interior heat back inside, and cool in the summer by blocking exterior heat, all while reducing harmful UV rays. The Global Low-E Glass Market: An Overview The global Low-E glass market is on a strong growth trajectory, driven by the

All 5 Releases


More Releases for Tularemia

Tularemia Treatment Market 2025 | Antibiotics Innovation, Vaccine Development & …
The Tularemia Treatment Market key growth drivers include increasing awareness and diagnosis of Tularemia, a rare but serious infectious disease caused by Francisella tularensis, along with rising incidence rates, government investment in biodefense and infectious disease preparedness, and ongoing advancements in antibiotic development and novel vaccines. Emerging opportunities focus on the development of new antibiotics to combat antimicrobial resistance, investigational vaccines for prevention, and the enhancement of rapid diagnostic tools.
Tularemia Therapeutic Market Size, Share, Trends, Growth & Forecast 2034
The Tularemia Therapeutic Market Is Set To Grow At An Estimated CAGR Of 7.2% From 2025 To 2034, Rising From $250 Million In 2024 To $500 Million By 2034. On April 16, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Tularemia Therapeutic market goods. The market study excludes key regions that are accelerating marketization. This section
Tularemia Treatment Market 2024 Projections, Trends, and Forecast 2024 - Pfizer …
The Tularemia Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Tularemia Treatment market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth. Download a
Tularemia Market Recent Technological Advancements to Propel Growth of the Marke …
In-depth study of the Global Tularemia Industry that helps to provide answers and relevant questions regarding the Emerging trends and Growth opportunities. It helps identify each of the major growth barriers aside from identifying the trends in the Tularemia market. Get Sample Copy of this Report @ https://www.theinsightpartners.com/sample/TIPRE00007565/?utm_source=OpenPR&utm_medium=10776 Tularemia refers to a disease that generally attacks the lymph nodes, skin, eyes, and lungs. It is also called rabbit fever or deer fly
Tularemia Infection Market - Industry Trends and Forecast to 2028
The Global Tularemia Infection Market Growth at a rate of 4.0% in the forecast period 2022 to 2028. The Global Tularemia Infection Market Size The tularemia infection market is segmented on the basis of type, treatment, drugs, vaccine, route of administration, end users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference
Tularemia Market 2020 Research Report On Insight Analysis by Essential Factors a …
Tularemia Market Analysis to 2027 is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Tularemia Market with detailed market segmentation by of type, diagnosis, drugs, end user and geography. The global Tularemia Market is expected to witness high growth during the forecast period. The report provides key statistics on the market